Compounds, Methods and Pharmaceutical Compositions for Treating Cellular Damage, such as Neural or Cardiovascular Tissue Damage

Details for Australian Patent Application No. 2005202592 (hide)

Owner Guilford Pharmaceuticals Inc.

Inventors Zhang, Jie; Li, Jia-He

Agent Cullen & Co

Pub. Number AU-B-2005202592

Parent 70871

Filing date 15 June 2005

Wipo publication date 7 July 2005

Acceptance publication date 19 June 2008

International Classifications

C07D 491/06 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

A61K 31/4748 (2006.01) - forming part of bridged ring systems

A61K 31/529 (2006.01) - forming part of bridged ring systems

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 35/00 (2006.01) Antineoplastic agents

C07D 221/00 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups

C07D 237/00 (2006.01) Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

C07D 237/26 (2006.01) Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

C07D 311/00 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

C07F 9/6561 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

Event Publications

30 June 2005 Complete Application Filed

7 July 2005 Application Open to Public Inspection

  Published as AU-B-2005202592

19 June 2008 Application Accepted

  Published as AU-B-2005202592

16 October 2008 Standard Patent Sealed

22 January 2009 Assignment Registered

  Guilford Pharmaceuticals Inc. The patent has been assigned to MGI GP, Inc.

9 April 2009 Assignment Registered

  MGI GP, Inc. The patent has been assigned to Eisai Corporation of North America

10 December 2009 Assignment Registered

  Eisai Corporation of North America The patent has been assigned to Eisai Inc.

29 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005202593-Sunscreen composition

2005202591-Frame assembly